BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22650177)

  • 1. Design and synthesis of a novel series of bicyclic heterocycles as potent γ-secretase modulators.
    Bischoff F; Berthelot D; De Cleyn M; Macdonald G; Minne G; Oehlrich D; Pieters S; Surkyn M; Trabanco AA; Tresadern G; Van Brandt S; Velter I; Zaja M; Borghys H; Masungi C; Mercken M; Gijsen HJ
    J Med Chem; 2012 Nov; 55(21):9089-106. PubMed ID: 22650177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of bicyclic heterocycles as potent γ-secretase modulators.
    Oehlrich D; Rombouts FJ; Berthelot D; Bischoff FP; De Cleyn MA; Jaroskova L; Macdonald G; Mercken M; Surkyn M; Trabanco AA; Tresadern G; Van Brandt S; Velter AI; Wu T; Gijsen HJ
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4794-800. PubMed ID: 23890837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iminoheterocycles as gamma-secretase modulators.
    Caldwell JP; Bennett CE; McCracken TM; Mazzola RD; Bara T; Buevich A; Burnett DA; Chu I; Cohen-Williams M; Josein H; Hyde L; Lee J; McKittrick B; Song L; Terracina G; Voigt J; Zhang L; Zhu Z
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5380-4. PubMed ID: 20724152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators.
    Qin J; Dhondi P; Huang X; Mandal M; Zhao Z; Pissarnitski D; Zhou W; Aslanian R; Zhu Z; Greenlee W; Clader J; Zhang L; Cohen-Williams M; Jones N; Hyde L; Palani A
    Bioorg Med Chem Lett; 2011 Jan; 21(2):664-9. PubMed ID: 21195610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of tetrahydroindazoles as a novel class of potent and in vivo efficacious gamma secretase modulators.
    Gerlach K; Hobson S; Eickmeier C; Groß U; Braun C; Sieger P; Garneau M; Hoerer S; Heine N
    Bioorg Med Chem; 2018 Jul; 26(12):3227-3241. PubMed ID: 29735425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization and biological evaluation of imidazopyridine derivatives as a novel scaffold for γ-secretase modulators with oral efficacy against cognitive deficits in Alzheimer's disease model mice.
    Sekioka R; Honda S; Akashiba H; Yarimizu J; Mitani Y; Yamasaki S
    Bioorg Med Chem; 2020 Jun; 28(11):115455. PubMed ID: 32307259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of aminothiazole modulators of the gamma-secretase enzyme.
    Rynearson KD; Buckle RN; Barnes KD; Herr RJ; Mayhew NJ; Paquette WD; Sakwa SA; Nguyen PD; Johnson G; Tanzi RE; Wagner SL
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3928-37. PubMed ID: 27426299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imidazo[1,2-a]pyridines: orally active positive allosteric modulators of the metabotropic glutamate 2 receptor.
    Trabanco AA; Tresadern G; Macdonald GJ; Vega JA; de Lucas AI; Matesanz E; García A; Linares ML; Alonso de Diego SA; Alonso JM; Oehlrich D; Ahnaou A; Drinkenburg W; Mackie C; Andrés JI; Lavreysen H; Cid JM
    J Med Chem; 2012 Mar; 55(6):2688-701. PubMed ID: 22352782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel scaffolds for γ-secretase modulators without an arylimidazole moiety.
    Sekioka R; Honjo E; Honda S; Fuji H; Akashiba H; Mitani Y; Yamasaki S
    Bioorg Med Chem; 2018 Jan; 26(2):435-442. PubMed ID: 29249626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piperidine-derived gamma-secretase modulators.
    Hall A; Elliott RL; Giblin GM; Hussain I; Musgrave J; Naylor A; Sasse R; Smith B
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1306-11. PubMed ID: 20056541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of piperazine derivatives as a novel class of γ-secretase modulators that selectively lower Aβ₄₂ production.
    Takai T; Koike T; Honda E; Kajita Y; Nakamura M; Morimoto S; Hoashi Y; Kamata M; Watanabe T; Igari T; Terauchi J
    Bioorg Med Chem; 2015 May; 23(9):1923-34. PubMed ID: 25842363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and pharmacological evaluation of a novel series of pyridopyrazine-1,6-dione γ-secretase modulators.
    Pettersson M; Johnson DS; Subramanyam C; Bales KR; am Ende CW; Fish BA; Green ME; Kauffman GW; Mullins PB; Navaratnam T; Sakya SM; Stiff CM; Tran TP; Xie L; Zhang L; Pustilnik LR; Vetelino BC; Wood KM; Pozdnyakov N; Verhoest PR; O'Donnell CJ
    J Med Chem; 2014 Feb; 57(3):1046-62. PubMed ID: 24428186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally bioavailable and brain-penetrant pyridazine and pyridine-derived γ-secretase modulators reduced amyloidogenic Aβ peptides in vivo.
    Huang Y; Li T; Eatherton A; Mitchell WL; Rong N; Ye L; Yang XJ; Jin S; Ding Y; Zhang J; Li Y; Wu Y; Jin Y; Sang Y; Cheng Z; Browne ER; Harrison DC; Hussain I; Wan Z; Hall A; Lau LF; Matsuoka Y
    Neuropharmacology; 2013 Jul; 70():278-86. PubMed ID: 23485401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, and Evaluation of a Novel Series of Oxadiazine Gamma Secretase Modulators for Familial Alzheimer's Disease.
    Bursavich MG; Harrison BA; Acharya R; Costa DE; Freeman EA; Hodgdon HE; Hrdlicka LA; Jin H; Kapadnis S; Moffit JS; Murphy DA; Nolan S; Patzke H; Tang C; Wen M; Koenig G; Blain JF; Burnett DA
    J Med Chem; 2017 Mar; 60(6):2383-2400. PubMed ID: 28230986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation.
    Mandal M; Zhu Z; Cumming JN; Liu X; Strickland C; Mazzola RD; Caldwell JP; Leach P; Grzelak M; Hyde L; Zhang Q; Terracina G; Zhang L; Chen X; Kuvelkar R; Kennedy ME; Favreau L; Cox K; Orth P; Buevich A; Voigt J; Wang H; Kazakevich I; McKittrick BA; Greenlee W; Parker EM; Stamford AW
    J Med Chem; 2012 Nov; 55(21):9331-45. PubMed ID: 22989333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of Aβ42 reduction in plasma, CSF and brain of rats treated with the γ-secretase modulator, GSM-10h.
    Hawkins J; Harrison DC; Ahmed S; Davis RP; Chapman T; Marshall I; Smith B; Mead TL; Medhurst A; Giblin GM; Hall A; Gonzalez MI; Richardson J; Hussain I
    Neurodegener Dis; 2011; 8(6):455-64. PubMed ID: 21389687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of an aminopiperidine series of γ-secretase modulators.
    Kobayashi T; Iwama S; Fusano A; Kato Y; Ikeda A; Teranishi Y; Nishihara A; Tobe M
    Bioorg Med Chem Lett; 2014 Jan; 24(1):378-81. PubMed ID: 24269163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of γ-secretase modulators with a novel activity profile by text-based virtual screening.
    Zettl H; Ness J; Hähnke V; Beher D; Jumpertz T; Saric A; Baumann K; Pietrzik CU; Bulic B; Schneider G; Weggen S
    ACS Chem Biol; 2012 Sep; 7(9):1488-95. PubMed ID: 22725102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent γ-secretase inhibitors/modulators interact with amyloid-β fibrils but do not inhibit fibrillation: a high-resolution NMR study.
    Yesuvadian R; Krishnamoorthy J; Ramamoorthy A; Bhunia A
    Biochem Biophys Res Commun; 2014 May; 447(4):590-5. PubMed ID: 24747079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment.
    Sjödin S; Andersson KK; Mercken M; Zetterberg H; Borghys H; Blennow K; Portelius E
    Alzheimers Res Ther; 2015 Dec; 7(1):77. PubMed ID: 26689589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.